8-K: VolitionRx Files Registration Statement for Warrant Shares

VolitionRx Limited has filed a new registration statement to register shares issuable upon the exercise of previously issued warrants.

Summary

• VolitionRx Limited filed a Registration Statement on Form S-1 with the SEC on April 4, 2025.
• The registration covers 35,867,306 shares of the company's common stock, which are issuable upon the exercise of previously issued warrants.
• These warrant shares were previously registered under a Shelf Registration Statement filed on September 24, 2021, and declared effective on November 8, 2021.
• VolitionRx intends to withdraw the warrant shares from the Shelf Registration Statement once the new registration statement is effective.
• The company is not registering any new shares beyond those previously registered.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing, indicating a neutral sentiment.

Future Outlook

The company intends to withdraw the Warrant Shares from the Shelf Registration Statement pursuant to Rule 477 of the Securities Act upon the declaration of effectiveness of the New Registration Statement by the SEC.

Management Comments

• Cameron Reynolds, Chief Executive Officer & President, signed the report on behalf of VolitionRx Limited.

Industry Context

This announcement is a routine regulatory filing related to the registration of shares underlying warrants, which is a common practice for publicly traded companies.

Stakeholder Impact

• Shareholders may see potential dilution upon the exercise of the warrants.
• The registration ensures the company can issue shares if warrant holders choose to exercise their rights.

Key Dates

Keywords

Registration Statement, Warrant Shares, VolitionRx, Form S-1, SEC, Common Stock